Ed Heslop joins Quadrant Biosciences as President of Viral Testing Division

Posted on December 18, 2020

SYRACUSE, NY, December 15, 2020 -- Quadrant Biosciences Inc., a developer of epigenetic diagnostic tools, announced that Ed Heslop has assumed the role of President of its recently created viral testing division, Quadrant Viral Testing LLC (“Quadrant Viral”). Quadrant Viral is a wholly owned subsidiary of Quadrant Biosciences established to manage wastewater surveillance of COVID-19, and other infectious diseases, in municipalities, nursing homes, colleges, office buildings and other communities. Mr. Heslop will be primarily responsible for spearheading the growth of Quadrant’s wastewater surveillance business.

Mr. Heslop has 40 years of entrepreneurial experience in the venture, non-medical life science industry. Prior to joining Quadrant, he was a founding member of businesses in agricultural production, development of rapid detection of carcinogens, innovative wastewater treatment, and climate change. He is an Executive in Residence at Cornell’s McGovern Center for Venture Life Sciences along with holding both a B.S. and M.S. from Cornell University.

"Ed is a great addition to our team,” said Richard Uhlig, Founder and CEO of Quadrant Biosciences. “He brings a wealth of entrepreneurial experience and strategic thinking to the table, and I’m confident he will play a critical role in the success of our wastewater surveillance business. Although our focus is currently on COVID-19 applications, we expect Quadrant Viral Testing to expand into testing other pathogens in the near future.”

“Having watched the development of Quadrant from the beginning I'm well aware of the vision and talents of the team,” said Mr. Heslop. “Seeing how they pivoted to focus their skills to develop one of the best in the world surveillance programs for COVID-19 monitoring is extremely impressive. When the time came I jumped at the opportunity to join the team.”

Since August, Quadrant has been involved in a pilot study funded by New York State to support wastewater testing in multiple municipalities and universities across the state. The aim of the study was to assess the efficacy of wastewater surveillance as an early warning system for identifying the relative prevalence of the SARS-CoV-2 virus in these larger populations. Following the successful completion of that study (documenting the ability to detect 1 infectious person in over 10,000), the company has been actively expanding the testing through its Quadrant Viral subsidiary to include additional universities, nursing homes, manufacturing, and communities. 

For inquiries about wastewater testing, please contact us at wastewater@quadrantbiosciences.com

For all general inquiries, contact us at info@quadrantbioscineces.com

Quadrant Biosciences is a life science company developing functional assessments and epigenetic diagnostic solutions for large-scale health issues. The company has entered into collaborative research relationships with a number of institutions including SUNY Upstate Medical University and Penn State University to explore and develop novel biomarker technologies with a focus on Autism Spectrum Disorder, concussion, and Parkinson's disease. Recently, it has leveraged its expertise in RNA analysis to address the COVID-19 pandemic. Quadrant participates in the Start-up NY program, a New York State economic development program. For more information about Quadrant, please visit www.quadrantbiosciences.com.


Other Member News

Kate Weidman, Deputy Executive Director, AURORA of CNY
July 19, 2024

AURORA of CNY Announces Leadership Changes

Weidman will transition into the role of Executive Director following the retirement of current Executive Director Debra Chaiken, ensuring a seamless succession in leadership.

Credit Score 101
July 17, 2024

Credit Score 101 - Everything You Need to Know

Understanding and managing your credit score is a key step towards achieving financial stability and success. 

Larry Bousquet
July 16, 2024

Crouse Health Board of Directors Welcomes Two New Members

The Crouse Health Board of Directors has appointed two new directors.

SUNY Press Release: SUNY Chancellor King Announces Launch of $6 Million Upstate Biotech Ventures
July 16, 2024

SUNY Chancellor King Announces Launch of $6 Million Upstate Biotech Ventures

Upstate Biotech Ventures will invest in Startups and Small Businesses affiliated with Upstate Medical University to drive research and technology innovation.

Home Buyer Seminar
July 15, 2024

Sidney Federal Credit Union Home Buying Seminar

Join us for an information packed hour, designed to help you navigate the mortgage process with confidence!

Impel Acquires Automotive Customer Engagement Platform Outsell in $100M+ Deal
July 15, 2024

Impel Acquires Automotive Customer Engagement Platform Outsell in $100M+ Deal

Adding Outsell’s data-driven outreach capabilities to Impel AI creates the auto industry’s first end-to-end global AI sales and marketing automation platform.

July 15, 2024

Patenting Biotechnology: CRISPR, Antibodies, Diagnostics, and Protein Based Biomaterials

The basic concepts of intellectual property law will be introduced.

Danyel Akins-Barbara Clark_Solvay Bank New Hires
July 12, 2024

Solvay Bank Announces Two Recent Hires

Solvay Bank, the oldest community bank established in Onondaga County, is pleased to welcome two recent hires to its team: Danyel Akins and Barbara Clark.

Harris Beach
July 12, 2024

Harris Beach and Murtha Cullina Partners Approve New Operating Agreement for Combined Firm

Both firms have approved an Operating Agreement that will govern a new, combined firm to be known as Harris Beach Murtha.